Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Counterfeit and Substandard Drugs in Myanmar and Viet Nam - Report of a Study Carried out in Cooperation with the Governments of Myanmar and Viet Nam - EDM Research Series N0. 029
(1999; 55 pages) Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentAcronyms and abbreviations
Afficher le documentExecutive summary
Afficher le document1. Introduction and background
Afficher le document2. What are counterfeit drugs?
Ouvrir ce répertoire et afficher son contenu3. The problem of counterfeit drugs
Ouvrir ce répertoire et afficher son contenu4. The WHO country study
Ouvrir ce répertoire et afficher son contenu5. Results of the study
Afficher le document6. Summary of findings
Afficher le document7. Conclusions and recommendations
Afficher le documentAnnex 1: Form for collecting information on pharmaceutical preparations sampled during field surveys
Afficher le documentAnnex 2: Questionnaire for collecting information on drug regulation and the problem of counterfeit drugs
Afficher le documentAnnex 3: Questionnaire for use in sample collection and investigation of samples
Afficher le documentReferences
 

Counterfeit and Substandard Drugs in Myanmar and Viet Nam - Report of a Study Carried out in Cooperation with the Governments of Myanmar and Viet Nam - EDM Research Series N0. 029

World Health Organization
Organisation mondiale de la Santé

WHO/EDM/QSM/99.3
English only
Distribution: Limited

Eshetu Wondemagegnehu

Essential Drugs and Other Medicines

Geneva 1999

Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developed countries. The Department of Essential Drugs and Other Medicines (EDM) Research Series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. EDM has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by EDM to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the EDM Research Series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.

© World Health Organization 1999

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).

This document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019